Sign In

Login

Password

Forgot Password ? Sign Up

Пухлинний маркер (Ukrainian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Пухлинний маркер" in Ukrainian language version.

refsWebsite
Global rank Ukrainian rank
11nih.gov
4th place
5th place
5doi.org
2nd place
4th place
2web.archive.org
1st place
1st place
1books.google.com
3rd place
11th place
1gpnotebook.co.uk
low place
9,800th place

books.google.com

doi.org

  • Keshaviah, A; Dellapasqua, S; Rotmensz, N; Lindtner, J; Crivellari, D; Collins, J; Colleoni, M; Thurlimann, B; Mendiola, C (2006). CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: A combined analysis of seven International Breast Cancer Study Group trials. Annals of Oncology. 18 (4): 701—8. doi:10.1093/annonc/mdl492. PMID 17237474.
  • Haug, U; Rothenbacher, D; Wente, M N; Seiler, C M; Stegmaier, C; Brenner, H (2007). Tumour M2-PK as a stool marker for colorectal cancer: Comparative analysis in a large sample of unselected older adults vs colorectal cancer patients. British Journal of Cancer. doi:10.1038/sj.bjc.6603712.
  • Schneider, J; Peltri, G; Bitterlich, N; Philipp, M; Velcovsky, HG; Morr, H; Katz, N; Eigenbrodt, E (2003). Fuzzy logic-based tumor marker profiles improved sensitivity of the detection of progression in small-cell lung cancer patients. Clinical and experimental medicine. 2 (4): 185—91. doi:10.1007/s102380300005. PMID 12624710.
  • Kumar, Yogesh; Tapuria, Niteen; Kirmani, Naveed; Davidson, Brian R. (2007). Tumour M2-pyruvate kinase: A gastrointestinal cancer marker. European Journal of Gastroenterology & Hepatology. 19 (3): 265. doi:10.1097/MEG.0b013e3280102f78.
  • Kaura, B; Bagga, R; Patel, FD (2004). Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma. The journal of obstetrics and gynaecology research. 30 (3): 193—6. doi:10.1111/j.1447-0756.2004.00187.x. PMID 15210041.

gpnotebook.co.uk

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Keshaviah, A; Dellapasqua, S; Rotmensz, N; Lindtner, J; Crivellari, D; Collins, J; Colleoni, M; Thurlimann, B; Mendiola, C (2006). CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: A combined analysis of seven International Breast Cancer Study Group trials. Annals of Oncology. 18 (4): 701—8. doi:10.1093/annonc/mdl492. PMID 17237474.
  • Osman N, O'Leary N, Mulcahy E, Barrett N, Wallis F, Hickey K, Gupta R (September 2008). Correlation of serum CA125 with stage, grade and survival of patients with epithelial ovarian cancer at a single centre. Ir Med J. 101 (8): 245—7. PMID 18990955.
  • Lüftner, D; Mesterharm, J; Akrivakis, C; Geppert, R; Petrides, PE; Wernecke, KD; Possinger, K (2000). Tumor type M2 pyruvate kinase expression in advanced breast cancer. Anticancer research. 20 (6D): 5077—82. PMID 11326672.
  • Benesch, C; Schneider, C; Voelker, HU; Kapp, M; Caffier, H; Krockenberger, M; Dietl, J; Kammerer, U; Schmidt, M (2010). The clinicopathological and prognostic relevance of pyruvate kinase M2 and pAkt expression in breast cancer. Anticancer research. 30 (5): 1689—94. PMID 20592362.
  • Oremek, GM; Sapoutzis, N; Kramer, W; Bickeböller, R; Jonas, D (2000). Value of tumor M2 (Tu M2-PK) in patients with renal carcinoma. Anticancer research. 20 (6D): 5095—8. PMID 11326675.
  • Wechsel, HW; Petri, E; Bichler, KH; Feil, G (1999). Marker for renal cell carcinoma (RCC): The dimeric form of pyruvate kinase type M2 (Tu M2-PK). Anticancer research. 19 (4A): 2583—90. PMID 10470199.
  • Schneider, J; Peltri, G; Bitterlich, N; Philipp, M; Velcovsky, HG; Morr, H; Katz, N; Eigenbrodt, E (2003). Fuzzy logic-based tumor marker profiles improved sensitivity of the detection of progression in small-cell lung cancer patients. Clinical and experimental medicine. 2 (4): 185—91. doi:10.1007/s102380300005. PMID 12624710.
  • Oremek, G; Kukshaĭte, R; Sapoutzis, N; Ziolkovski, P (2007). The significance of TU M2-PK tumor marker for lung cancer diagnostics. Klinicheskaia meditsina. 85 (7): 56—8. PMID 17882813.
  • Hardt, PD; Ngoumou, BK; Rupp, J; Schnell-Kretschmer, H; Kloer, HU (2000). Tumor M2-pyruvate kinase: A promising tumor marker in the diagnosis of gastro-intestinal cancer. Anticancer research. 20 (6D): 4965—8. PMID 11326648.
  • Kaura, B; Bagga, R; Patel, FD (2004). Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma. The journal of obstetrics and gynaecology research. 30 (3): 193—6. doi:10.1111/j.1447-0756.2004.00187.x. PMID 15210041.
  • Ahmed, AS; Dew, T; Lawton, FG; Papadopoulos, AJ; Devaja, O; Raju, KS; Sherwood, RA (2007). M2-PK as a novel marker in ovarian cancer. A prospective cohort study. European journal of gynaecological oncology. 28 (2): 83—8. PMID 17479666.

web.archive.org